Overview

Therapeutic Variables in Cataract Surgery

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Treatments:
Gatifloxacin
Ketorolac
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Moxifloxacin
Nepafenac
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate